Patent · US Active

Compositions and methods for antibodies targeting EPO

US9365646B2 · kind B2 · utility

3Cited by

3References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Joy Ghosh · Boston, US
Mark Rutz · Martinsried, DE
Kathrin Ulrike Tissot-Daguette · Schwanau, DE
Igor Splawski · Winchester, US
Michael Roguska · Cambridge, US

Key dates

Filing date	Dec 3, 2013
Grant date	Jun 14, 2016
Priority date	—
Expiry date	Dec 8, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.